A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent acquisition of sexually transmitted diseases

Amsel R., Totten P.A., Spiegel C.A., Chen K.C.S., Eschenbach D., Holmes K.K., Non-specific vaginitis: diagnostic and microbial and epidemiological associations, Am J Med, 74, pp. 14-22, (1983)

Cohen M.S., Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis, Lancet, 351, pp. 5-7, (1998)

Cherpes T., Meyn L., Krohn M.A., Lurie J., Hillier S.L., Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis, Clin Infect Dis, 37, pp. 319-325, (2003)

Watts D., Fazarri M., Minkoff H., Et al., Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1- infected and high-risk HIV-1-uninfected women, J Infect Dis, 191, pp. 1129-1139, (2005)

Hillier S., The vaginal microbial ecosystem and resistance to HIV, AIDS, 14, pp. 17-21, (1998)

Klebanoff S.J., Hillier S.L., Eschenbach D.A., Waltersdorph A.M., Control of the microbial flora of the vagina by H₂O₂ -generating lactobacilli, J Infect Dis, 164, pp. 94-100, (1991)

Grosskurth H., Mosha F., Todd J., Et al., Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial, Lancet, 346, pp. 530-536, (1995)

Wawer M., Sewankambo N., Serwadda D., Quinn T., Paxton L., Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial, Lancet, 353, pp. 525-535, (1999)

Sexually transmitted diseases treatment guidelines, MMWR Recomm Rep, 55, pp. 49-56, (2006)

Sobel J., Ferris D., Schwebke J., Et al., Suppressive maintenance antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis, Am J Obstet Gynecol, 194, pp. 1283-1289, (2006)

Amsel R., Totten P.A., Spiegel C.A., Chen K.C.S., Eschenbach D., Holmes K.K., Non-specific vaginitis: diagnostic and microbial and epidemiological associations, Am J Med, 74, pp. 14-22, (1983)

Cohen M.S., Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis, Lancet, 351, pp. 5-7, (1998)

Cherpes T., Meyn L., Krohn M.A., Lurie J., Hillier S.L., Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis, Clin Infect Dis, 37, pp. 319-325, (2003)

Watts D., Fazarri M., Minkoff H., Et al., Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1- infected and high-risk HIV-1-uninfected women, J Infect Dis, 191, pp. 1129-1139, (2005)

Hillier S., The vaginal microbial ecosystem and resistance to HIV, AIDS, 14, pp. 17-21, (1998)

Klebanoff S.J., Hillier S.L., Eschenbach D.A., Waltersdorph A.M., Control of the microbial flora of the vagina by H₂O₂ -generating lactobacilli, J Infect Dis, 164, pp. 94-100, (1991)

Grosskurth H., Mosha F., Todd J., Et al., Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial, Lancet, 346, pp. 530-536, (1995)

Wawer M., Sewankambo N., Serwadda D., Quinn T., Paxton L., Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial, Lancet, 353, pp. 525-535, (1999)

Sexually transmitted diseases treatment guidelines, MMWR Recomm Rep, 55, pp. 49-56, (2006)

Sobel J., Ferris D., Schwebke J., Et al., Suppressive maintenance antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis, Am J Obstet Gynecol, 194, pp. 1283-1289, (2006)